Taiwan's FDA Authorizes Maryland's COVID-19 Vaccine

The Taiwan Food and Drug Administration (FDA) recently granted emergency use authorization for the Novavax COVID-19 vaccine for adults. Local media reported Taiwan FDA experts agreed to approve Novavax's Nuvaxovid™, the first protein-based vaccine per Taiwan's pharmaceutical laws, on June 17, 2022.

Related Keywords

Australia ,Taiwan ,Gaithersburg ,Maryland ,United States ,Australian ,Chen Shih Chung ,Novavax Nuvaxovid ,Australian Therapeutic Goods Administration ,Vaccine Committee ,Drug Administration ,Novavax Inc ,Precision Vaccinations ,Taiwan Food ,Welfare Chen Shih Chung ,Novavax ,Vaccine ,